Webinars
- Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers
- Successful Strategies for Patient Screening and Stratification
- Decentralised Trials in Psychiatry: From Feasibility to Novel Insights
- Novel Digital Technologies and Biomarkers to Characterise Depression
- Digital Health Event 2021: Integrating multimodal data to meet clinical challenges
- Voice Technology in Clinical Trials
- Virtual clinical trials: What have we learned in the era of Covid-19?
- Remote Cognitive Testing and Lessons Learned During Lockdown
- Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
- Elderly patients in clinical trials: addressing the evidence-practice gap
- Future directions in eCOA: Innovations in high-frequency and automated voice-based testing
- Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening?
- Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape
- Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
- Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond
- Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success
- Assessing Cognitive Safety of Drugs in Clinical Development
- Understanding the Clinical Assessment of Abuse Potential during CNS Drug Development
- Leveraging Cognitive Measures in Clinical Trials
